Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian T Collins

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Frontiers in Oncology|June 2, 2012
CyberKnife with Tumor Tracking: An Effective Treatment for High-Risk Surgical Patients with Stage I Non-Small Cell Lung CancerViola J Chen, Eric Oermann, Saloomeh Vahdat, et al.
Journal of Neurosurgery|September 10, 2013
The impact of radiosurgery fractionation and tumor radiobiology on the local control of brain metastasesEric K Oermann, Marie-Adele S Kress, Jonathan V Todd, et al.
Advances in Radiation Oncology|December 29, 2022
High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and ImmunotherapyMichael Carrasquilla, Nitika Paudel, Brian T Collins, et al.
Frontiers in Oncology|July 4, 2012
CyberKnife with Tumor Tracking: An Effective Treatment for High-Risk Surgical Patients with Single Peripheral Lung MetastasesJames W Snider, Eric K Oermann, Viola Chen, et al.
Radiation Oncology (London, England)|October 28, 2015
Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastasesJonathan W Lischalk, Eric Oermann, Sean P Collins, et al.
Journal of Hematology & Oncology|October 26, 2010
CyberKnife for hilar lung tumors: report of clinical response and toxicityKeith Unger, Andrew Ju, Eric Oermann, et al.
Frontiers in Oncology|August 10, 2017
Prostate-Specific Antigen 5 Years following Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: An Ablative Procedure?Shaan Kataria, Harsha Koneru, Shan Guleria, et al.
Acta Oncologica (Stockholm, Sweden)|March 9, 2017
Predictors of acute urinary symptom flare following stereotactic body radiation therapy (SBRT) in the definitive treatment of localized prostate cancerMichael C Repka, Thomas P Kole, Jacqueline Lee, et al.
Frontiers in Oncology|March 15, 2021
Ten-Year Single Institutional Analysis of Geographic and Demographic Characteristics of Patients Treated With Stereotactic Body Radiation Therapy for Localized Prostate CancerNima Aghdam, Michael Carrasquilla, Edina Wang, et al.
Frontiers in Oncology|February 11, 2020
Self-Reported Burden in Elderly Patients With Localized Prostate Cancer Treated With Stereotactic Body Radiation Therapy (SBRT)Nima Aghdam, Abigail Pepin, Michael Carrasquilla, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Frontiers in Oncology|June 2, 2012
CyberKnife with Tumor Tracking: An Effective Treatment for High-Risk Surgical Patients with Stage I Non-Small Cell Lung CancerViola J Chen, Eric Oermann, Saloomeh Vahdat, et al.
Journal of Neurosurgery|September 10, 2013
The impact of radiosurgery fractionation and tumor radiobiology on the local control of brain metastasesEric K Oermann, Marie-Adele S Kress, Jonathan V Todd, et al.
Advances in Radiation Oncology|December 29, 2022
High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and ImmunotherapyMichael Carrasquilla, Nitika Paudel, Brian T Collins, et al.
Frontiers in Oncology|July 4, 2012
CyberKnife with Tumor Tracking: An Effective Treatment for High-Risk Surgical Patients with Single Peripheral Lung MetastasesJames W Snider, Eric K Oermann, Viola Chen, et al.
Radiation Oncology (London, England)|October 28, 2015
Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastasesJonathan W Lischalk, Eric Oermann, Sean P Collins, et al.
Journal of Hematology & Oncology|October 26, 2010
CyberKnife for hilar lung tumors: report of clinical response and toxicityKeith Unger, Andrew Ju, Eric Oermann, et al.
Frontiers in Oncology|August 10, 2017
Prostate-Specific Antigen 5 Years following Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: An Ablative Procedure?Shaan Kataria, Harsha Koneru, Shan Guleria, et al.
Acta Oncologica (Stockholm, Sweden)|March 9, 2017
Predictors of acute urinary symptom flare following stereotactic body radiation therapy (SBRT) in the definitive treatment of localized prostate cancerMichael C Repka, Thomas P Kole, Jacqueline Lee, et al.
Frontiers in Oncology|March 15, 2021
Ten-Year Single Institutional Analysis of Geographic and Demographic Characteristics of Patients Treated With Stereotactic Body Radiation Therapy for Localized Prostate CancerNima Aghdam, Michael Carrasquilla, Edina Wang, et al.
Frontiers in Oncology|February 11, 2020
Self-Reported Burden in Elderly Patients With Localized Prostate Cancer Treated With Stereotactic Body Radiation Therapy (SBRT)Nima Aghdam, Abigail Pepin, Michael Carrasquilla, et al.
Pageof 13